139 related articles for article (PubMed ID: 918118)
1. Clinical experiences with tamoxifen for estrogen receptor blocking therapy in metastatic breast cancer.
Henningsen B
Prog Clin Biol Res; 1977; 12():479-82. PubMed ID: 918118
[No Abstract] [Full Text] [Related]
2. [Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)].
Henningsen B; Amberger H
Dtsch Med Wochenschr; 1977 May; 102(19):713-6. PubMed ID: 870301
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer.
Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
Oncol Rep; 2003; 10(1):141-4. PubMed ID: 12469160
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Spremulli EN; Raney M; Logan T
Cancer Treat Rep; 1986 Oct; 70(10):1199-203. PubMed ID: 3530447
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen in advanced male breast cancer.
Aisner J; Ross DD; Wiernik PH
Arch Intern Med; 1979 Apr; 139(4):480-1. PubMed ID: 435005
[TBL] [Abstract][Full Text] [Related]
6. [Results of anti-estrogen therapy in metastatic breast cancer (preliminary results). Part II].
Firusian N; Schmidt CG
Med Welt; 1977 Dec; 28(51-52):2065-7. PubMed ID: 414049
[No Abstract] [Full Text] [Related]
7. Anti-oestrogen therapy for breast cancer--a report on 300 patients treated with tamoxifen.
Ward HW; Arthur K; Banks AJ; Bond WH; Brown I; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ostrowski MJ
Clin Oncol; 1978 Mar; 4(1):11-7. PubMed ID: 639375
[No Abstract] [Full Text] [Related]
8. Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).
Ciocca DR; Green S; Elledge RM; Clark GM; Pugh R; Ravdin P; Lew D; Martino S; Osborne CK
Clin Cancer Res; 1998 May; 4(5):1263-6. PubMed ID: 9607585
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of the antioestrogenic agent tamoxifen in the treatment of metastatic breast cancer (author's transl)].
Szepesi T; Czech W
Wien Klin Wochenschr; 1978 Feb; 90(4):133-41. PubMed ID: 625990
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogen-induced remissions in stage IV breast cancer.
Manni A; Trujillo J; Marshall JS; Pearson OH
Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
[TBL] [Abstract][Full Text] [Related]
11. [Antiestrogens: a new endocrine treatment possibility in metastasizing breast neoplasms. Experiences of the Swiss Cooperative Cancer Study Group with tamoxifen].
Jungi WF; Alberto P; Wagenknecht L; Cavalli F; Martz G; Brunner KW
Schweiz Med Wochenschr; 1978 Aug; 108(34):1317-21. PubMed ID: 694481
[TBL] [Abstract][Full Text] [Related]
12. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.
Namer M; Lalanne C; Baulieu EE
Cancer Res; 1980 May; 40(5):1750-2. PubMed ID: 7371003
[TBL] [Abstract][Full Text] [Related]
13. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
[No Abstract] [Full Text] [Related]
15. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
16. [Tamoxifen-induced progesterone receptors in breast tumors].
Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
[TBL] [Abstract][Full Text] [Related]
17. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R
Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970
[No Abstract] [Full Text] [Related]
18. Tamoxifen for breast cancer.
Med Lett Drugs Ther; 1978 May; 20(9):41-2. PubMed ID: 642872
[No Abstract] [Full Text] [Related]
19. [Effects and mechanism of action of antiestrogens in breast cancer].
Borgna JL; Rochefort H
Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
